BioSpace News Archive

OneOncology Research Network Will Enhance Practices’ High-Quality Clinical Trials Programs While Improving Patients’ Access to Innovative Oncology Therapies

Teleflex Incorporated announced that financial results for the third quarter 2020 will be released before market open on Thursday, October 29, 2020.

Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization for ‘CentoSure’, the company’s latest SARS-CoV-2 RT-PCR test.

New preclinical study finds boosting NAD+ with nicotinamide riboside alleviated telomere damage, providing protective effect to DNA strands

Tarrytown Expocare (“Tarrytown” or “The Company”), a portfolio company of Sheridan Capital Partners, announced today the completed acquisitions of Long’s Drugs, located in Thomson, Georgia, Long’s Closed-Door Pharmacy, located in Columbia, South Carolina, and Adler’s Pharmacy LTC, located in Cherry Hill, NJ. These acquisitions are the latest completed by Tarrytown as the Company continues expanding into new states in order to pr

Amarin Corporation plc announced that it will host a conference call with members of Amarin senior management to discuss the company’s third quarter 2020 financial results and provide an operational update on Thursday, November 5, 2020, at 7:30 a.m. ET.

150ppm nitric oxide was statistically significant compared to both control and 85ppm nitric oxide arms on the primary and key secondary endpoints

CareDx, Inc. announced that the Centers for Medicare and Medicaid Services recently issued a memo recommending continued coverage of AlloMap through local Medicare Administrative Contractors.

Clinical trial will evaluate the effectiveness of MediPharm Labs proprietary GMP cannabis-derived formulations and medical products and expand MediPharm Labs owned IP In the United States, 37 million or more than 1 in 7 adults, are estimated to have chronic kidney disease (CKD) and Worldwide, approximately 1 in 10 people suffer from kidney disease according to the National Kidney Foundation Patients with CKD suffer from various symptoms and have limited life expectancy, consequently, optimi

Ms. Richner is an experienced public health policy professional with over 30 years of experience in Medical Devices, Reimbursement Strategy and Health Care Policy